Peptide therapeutics are gaining popularity as potential treatment alternatives to traditional small molecule drugs. Peptides allow for highly targeted interactions and demonstrate excellent biocompatibility and low toxicity compared to synthetic drugs. Peptides are increasingly being used for conditions like cancer, metabolic disorders, CVD and infectious diseases. Key pathways targeted include GPCRs, ion channels and nuclear receptors. The commercial success of therapies like GOOFEST (liraglutide), BYETTA (exenatide) and Taltz (ixekizumab) have further validated peptides as a therapeutic modality.
Key players operating in the Peptide Therapeutics are IBM Corporation, SAP SE, Oracle Corporation, ABB Ltd., Infor, Inc., Ultimo Software Solutions BV, CARL International SA, eMaint Enterprises, LLC, Mainsaver, Inc., MEX Pty Ltd., Asset Works LLC, and CGI, Inc. The global peptide therapeutics market is witnessing considerable traction due to increasing demand for biologics and biosimilars. The rising prevalence of metabolic disorders such as obesity and diabetes along with growing adoption of peptide-based drugs are expected to drive market growth. Technological advancements in peptide design and synthesis techniques have augmented the potential of peptides in clinical applications.
Market Trends
1. Increased R&D Investments: Leading pharma companies are ramping up investments in peptide drug discovery and development programs to capitalize on the market potential of these drugs. 2. Adoption of Novel Drug Delivery Systems: To overcome stability and bioavailability issues, researchers are exploring new delivery routes like pulmonary and transdermal along with nanoparticulate formulations for improved peptide therapeutics.
Market Opportunities
1. Untapped Therapeutic Areas: Peptides hold promise for conditions like neurological disorders, rare diseases and rejection post-transplant where current treatment options are limited.
2. Biosimilars Market Growth: As patents of blockbuster peptide drugs expire, biosimilars provide lucrative commercialization opportunities for both innovator and generic manufacturers.
Impact of COVID-19 on Peptide Therapeutics Market
The COVID-19 pandemic has negatively impacted the growth of the Global Peptide Therapeutics Market Size. During the initial lockdown phases enforced by various governments worldwide, the manufacturing and supply chain were disrupted. This led to delays in drug development activities and caused shortage of important drugs. The pandemic also restricted clinical trials, posing challenges for the development of novel peptide-based drugs. However, with time, the market is recovering as manufacturing and supply chains are being restored. The demand for peptides used to treat COVID-19 patients is increasing and companies are investing in R&D to expedite drug discovery efforts. Post-pandemic, the focus on developing new therapeutic options is expected to drive higher growth.
Geographical Regions with Highest Market Concentration
In terms of value, North America accounts for the largest share of the global peptide therapeutics market currently. This can be attributed to factors such as established healthcare facilities, growing incidence of chronic diseases, expanding biopharmaceutical industry, and increasing adoption of advanced treatment options in the region. The US dominates the North American market owing to presence of major players and growing usage of innovative therapies. Asia Pacific is emerging as the fastest growing regional market due to rising healthcare spending, large patient pool, and improving access to specialty treatments.
Fastest Growing Region for Peptide Therapeutics Market
Asia Pacific is poised to witness the fastest growth over the forecast period in the global peptide therapeutics market. This is because of rapidly developing economies, increasing disposable incomes, rising awareness about modern therapies, and expanding healthcare infrastructure in Asia Pacific countries. Furthermore, continuous growth in the aging population which is more prone to chronic conditions also contributes to boosting the market. Governments are supporting local manufacturing to provide affordable treatments to mass population. Due to these factors, Asia Pacific is anticipated to offer lucrative opportunities for players in the peptide therapeutics industry.
Get More Insights On This Topic: https://www.newswirestats.com/peptide-therapeutics-market-set-to-witness-high-growth-owing/
Comments
0 comment